S Eichinger, G Hron, C Bialonczyk, M Hirschl, … - Archives of Internal Medicine, 2008 - Am Med Assoc Results A total of 168 patients had recurrent venous thromboembolism. Mean (SD)
body mass index (BMI) (calculated as weight in kilograms divided by height in
meters squared) was significantly higher among patients with recurrence ... Cited by 16 - Related articles - All 5 versions
- ►prsjournal.net P Prandoni, MM Samama - British Journal of Haematology, 2008 - pt.wkhealth.com Acute venous thromboembolism (VTE) is a serious and potentially fatal disorder,
which often complicates the course of hospitalized medical patients. This is
particularly true for carriers of malignant diseases. While the ... Cited by 12 - Related articles - BL Direct - All 7 versions
- ►uniklinikum-jena.de [PDF] S Eichinger, G Hron, M Kollars, PA Kyrle - Clinical Chemistry, 2008 - Am Assoc Clin Chem Background: Increased thrombin generation is associated with an increased risk
of recurrent venous thromboembolism. We investigated the relation between
endogenous thrombin potential (ETP) and risk of recurrent venous ... Cited by 11 - Related articles - All 7 versions
RH White, H Zhou, S Murin - Thrombosis and haemostasis, 2008 - ncbi.nlm.nih.gov The incidence of death due to recurrent pulmonary embolism (PE) after a
first-time idiopathic PE is not well defined. We conducted a retrospective study
of patients age 18 to 56 years who had idiopathic PE between 1994-2001. The ... Cited by 5 - Related articles - BL Direct - All 2 versions
G Meyer, B Planquette, O Sanchez - Therapy, 2008 - Future Medicine The risk of death after an episode of acute pulmonary embolism is less than 5%,
provided that the patient is hemodynamically stable and free of major underlying
disease. In unselected patients, pulmonary embolism and recurrent disease ... Cited by 4 - Related articles - BL Direct - All 4 versions
P Prandoni, MH Prins, AWA Lensing, A … - Ann Intern Med, 2009 - Am Coll Physicians Paolo Prandoni, MD, PhD; Martin H. Prins, MD, PhD; Anthonie WA Lensing, MD, PhD;
Angelo Ghirarduzzi, MD; Walter Ageno, MD; Davide Imberti, MD; Gianluigi
Scannapieco, MD; Giovanni B. Ambrosio, MD; Raffaele Pesavento, MD; Stefano ... Cited by 5 - Related articles - All 10 versions
- ►nursing2008.com T Zhu, I Martinez, J Emmerich - Arteriosclerosis, Thrombosis, and Vascular Biology, 2009 - Am Heart Assoc Patients who have a first episode of venous thromboembolism (VTE) have an
elevated risk of a recurrent episode, and this necessitates secondary
prophylaxis. Anticoagulant therapy is a double-edged sword, however, as it ... Cited by 5 - Related articles - All 7 versions
L Eischer, V Gartner, S Schulman, PA Kyrle, S … - Annals of Hematology, 2009 - Springer Abstract Patients with first venous thromboembolism (VTE) and high factor VIII
(FVIII) are at increased risk of recurrence. It is unknown whether these
patients benefit from prolonged secondary thrombophrophylaxis. In a ... Cited by 2 - Related articles - All 2 versions
M Carrier, LE GAL - Journal of Thrombosis and Haemostasis, 2009 - interscience.wiley.com Background: Cancer patients with venous thromboembolism (VTE) are at high risk
of recurrent VTE despite standard anticoagulation. To date, very little
published literature is available to guide treatment of cancer patients ... Cited by 2 - Related articles - All 5 versions
PA Kyrle, S Eichinger - The Lancet, 2008 - Elsevier Venous thromboembolism is a typical multifactorial disease. 2 The most important
risk factors are acquired and include advanced age, surgery or trauma, cancer,
immobilisation, acute medical illnesses, or intake of exogenous female ... Cited by 2 - Related articles - All 4 versions
